Loading patent…
AssigneeR.E.D. Laboratories, N.V.
InventorsSimon Adriaan Michiel Roelens, Patrick Englebienne, Anne Marie Yvonne Robert D'Haese, C. V. Taylor Herst
Estimating the term…
Methods are provided for diagnosing and/or characterizing chronic immune disease activity in a subject. In the subject methods, a sample is obtained from a subject suspected of having or known to have a chronic immune disease. The sample is then assayed for the presence of low molecular actin fragments. The assay results are used to diagnose the presence of chronic immune disease activity and/or characterize chronic immune disease activity in the subject, e.g. to confirm an initial chronic immune disease diagnosis, to determine the stage of the disease, to monitor disease progression, to predict disease attacks, and the like. Also provided by the subject invention are kits for practicing the methods.
A method for diagnosing whether a host suffers from a chronic immune disease, said method comprising:
A method of characterizing chronic immune disease activity in a human subject, said method comprising:
A method of characterizing a chronic immune disease activity in a human subject, said method comprising:
A kit for use in characterizing a chronic immune disease activity in a subject, said kit comprising:
An method for determining at least one of RNase L and actin proteolytic activity in a sample, said method comprising:
A method for characterizing chronic immune disease activity in a subject, said method comprising:
A kit for use in assaying a sample for at least one of RNase L or actin proteolytic activity, said kit comprising:
Dependencies are inferred from the claim text.